1 2 3 

THOUSAND OAKS, Calif., March 23, 2020-Amgen and the Amgen Foundation today announced an initial commitment of up to $12.5 million to support U.S. and global relief efforts to address critical needs in communities impacted by the COVID-19 pandemic.

Entos Pharmaceuticals (Entos), a healthcare biotechnology company that develops next generation nucleic acid medicines using the Fusogenix drug delivery platform, today announced their development of a Fusogenix DNA vaccine to prevent COVID-19 infections.

Regenerative medicine is fascinating business. BioTechCanada is asking you to answer the call for the AMGEN BIONATION Regenerative Medicine Innovation Challenge 2020!

See details & requirements for proposals and apply now at www.bionation.ca

The 6th cycle of Partnership for Research & Innovation in the Health System (PRIHS) is now live!

The newly streamlined Alberta Export Expansion Program reduces red tape for local businesses looking to expand around the world.

Life Sciences Innovation Hub Members and Tenants can access up to 100 hours of free consultancy from a talented roster of 25 Expert Advisors located across Canada and parts of the U.S.

1 2 3